At a glance
ClinicalIndex Comparison RecordN/AActive· 228 enrolled
Drug / intervention
Transcatheter Tricuspid Valve Replacementdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
In Brief
A clinical study evaluating Transcatheter Tricuspid Valve Replacement for Tricuspid Valve Regurgitation and 2 related conditions. Active but no longer recruiting, targeting 228 participants across 20 sites in 4 countries.
Detailed Summary
Prospective, multi-center study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, France, Switzerland, United States
Collaborators--
Timeline
N/AActive
2020202120222023202420252026202720282029
First PostedJan 2020
Enrollment StartMay 2020
Primary CompletionJan 2024
TodayJul 2026
Study CompletionJan 2029
First PostedJan 9, 2020
Enrollment StartMay 6, 2020
Primary CompletionJan 5, 2024
Study CompletionJan 31, 2029
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 6.5 years ago
Interventions
Transcatheter Tricuspid Valve Replacementdevice
Replacement of the tricuspid valve through a transcatheter approach